Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 49 citations in OpenAlex.

1. Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial.Journal of the American Heart Association · 2024
   Trial
2. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.Annals of the rheumatic diseases · 2023
   Trial
3. The Lipid Paradox as a Metabolic Checkpoint and Its Therapeutic Significance in Ameliorating the Associated Cardiovascular Risks in Rheumatoid Arthritis Patients.International journal of molecular sciences · 2020
   Review
4. Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.Nature reviews. Rheumatology · 2019 · on this map
   Review
5. Cardiometabolic Disorders in Psoriatic Disease.Current rheumatology reports · 2017
   Review
6. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.Clinical rheumatology · 2017
   Observational
7. Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases.RMD open · 2017
   Article
8. Prevention of stroke in rheumatoid arthritis.Current treatment options in neurology · 2015
   Article
9. Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study.Arthritis research & therapy · 2015
   Article
10. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.Rheumatology (Oxford, England) · 2014
    Review
11. Adiponectin and atherosclerosis in rheumatoid arthritis.Mediators of inflammation · 2014
    Article
12. Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis.PloS one · 2014
    Article
13. Statins do not influence long-term rituximab clinical efficiency in rheumatoid arthritis patients.BioMed research international · 2014
    Article
14. SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis.Arthritis research & therapy · 2013
    Article
15. Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Therapeutic advances in musculoskeletal disease · 2013
    Article
16. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis.Seminars in arthritis and rheumatism · 2012
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as